IT1272990B - "composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione edapplicazione". - Google Patents
"composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione edapplicazione".Info
- Publication number
- IT1272990B IT1272990B ITRM940322A ITRM940322A IT1272990B IT 1272990 B IT1272990 B IT 1272990B IT RM940322 A ITRM940322 A IT RM940322A IT RM940322 A ITRM940322 A IT RM940322A IT 1272990 B IT1272990 B IT 1272990B
- Authority
- IT
- Italy
- Prior art keywords
- treatment
- pharmaceutical composition
- carbazolone
- headache
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invenzione si riferisce ad una composizione farmaceutica per somministrazione rettale comprendente 1, 2, 3, 9-tetraidro-9-metil-3[(2-metil-1H-imidazol-1-il) metil]-4H-carbazol-4-one sotto forma di sua base libera oppure di un suo solvato farmaceuticamente accettabile come ingrediente attivo, insieme con uno o più veicoli od eccipienti farmaceuticamente accettabili.Vengono anche descritti metodi per la produzione di tali composizioni e per il loro impiego nel trattamento di condizioni mediate dall'azione di 5-idrossitriptamina in corrispondenza di 5-HT3 recettori.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939310756A GB9310756D0 (en) | 1993-05-25 | 1993-05-25 | Compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ITRM940322A0 ITRM940322A0 (it) | 1994-05-24 |
| ITRM940322A1 ITRM940322A1 (it) | 1995-11-24 |
| IT1272990B true IT1272990B (it) | 1997-07-01 |
Family
ID=10736089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITRM940322A IT1272990B (it) | 1993-05-25 | 1994-05-24 | "composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione edapplicazione". |
Country Status (38)
| Country | Link |
|---|---|
| US (1) | US5741806A (it) |
| EP (1) | EP0700290B1 (it) |
| JP (1) | JP2965703B2 (it) |
| KR (1) | KR100297212B1 (it) |
| CN (1) | CN1106194C (it) |
| AP (1) | AP544A (it) |
| AT (1) | ATE183643T1 (it) |
| AU (1) | AU680918B2 (it) |
| BE (1) | BE1007158A3 (it) |
| BR (1) | BR1100046A (it) |
| CA (1) | CA2162919C (it) |
| CO (1) | CO4230094A1 (it) |
| CY (1) | CY2411B1 (it) |
| CZ (1) | CZ291041B6 (it) |
| DE (1) | DE69420266T2 (it) |
| DK (1) | DK0700290T3 (it) |
| EC (1) | ECSP941088A (it) |
| ES (1) | ES2136198T3 (it) |
| FR (1) | FR2705569B1 (it) |
| GB (2) | GB9310756D0 (it) |
| GR (1) | GR3031669T3 (it) |
| HR (2) | HRP940315B1 (it) |
| HU (1) | HU227121B1 (it) |
| IE (1) | IE80632B1 (it) |
| IL (1) | IL109749A (it) |
| IS (1) | IS1868B (it) |
| IT (1) | IT1272990B (it) |
| MY (1) | MY111445A (it) |
| NO (1) | NO306448B1 (it) |
| NZ (1) | NZ267415A (it) |
| PE (1) | PE13395A1 (it) |
| PL (1) | PL175578B1 (it) |
| RU (1) | RU2132684C1 (it) |
| SA (1) | SA94150003B1 (it) |
| SG (1) | SG48119A1 (it) |
| SI (1) | SI0700290T1 (it) |
| WO (1) | WO1994027599A1 (it) |
| ZA (1) | ZA943593B (it) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003522103A (ja) * | 1998-06-15 | 2003-07-22 | セプラコア インコーポレーテッド | 無呼吸、過食症およびその他の障害を治療するための光学的に純粋な（−）−ノルシスアプリドの使用 |
| EP1468685A3 (en) * | 1998-06-15 | 2004-12-15 | Sepracor Inc. | Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders |
| EP1464333A3 (en) * | 1998-06-15 | 2004-12-15 | Sepracor Inc. | Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders |
| EP1089733B1 (en) | 1998-06-15 | 2005-03-23 | Sepracor Inc. | Use of optically pure (+)-norcisapride for treating irritable bowel syndrome |
| US6362202B1 (en) | 1999-03-02 | 2002-03-26 | Sepracor Inc. | Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists |
| US6353005B1 (en) | 1999-03-02 | 2002-03-05 | Sepracor, Inc. | Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist |
| AU7931301A (en) * | 2000-08-04 | 2002-02-18 | Dmi Biosciences Inc | Method of using diketopiperazines and composition containing them |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR920003064B1 (ko) * | 1984-01-25 | 1992-04-13 | 글락소 그룹 리미티드 | 헤테로시클릭 화합물의 제조방법 |
| US4695578A (en) * | 1984-01-25 | 1987-09-22 | Glaxo Group Limited | 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances |
| GB8627909D0 (en) * | 1986-11-21 | 1986-12-31 | Glaxo Group Ltd | Medicaments |
| GB8816187D0 (en) * | 1988-07-07 | 1988-08-10 | Glaxo Group Ltd | Medicaments |
| US5166145A (en) * | 1990-09-10 | 1992-11-24 | Alza Corporation | Antiemetic therapy |
-
1993
- 1993-05-25 GB GB939310756A patent/GB9310756D0/en active Pending
-
1994
- 1994-05-17 EC EC1994001088A patent/ECSP941088A/es unknown
- 1994-05-17 GB GB9409835A patent/GB2279008B/en not_active Expired - Lifetime
- 1994-05-17 SG SG1996007139A patent/SG48119A1/en unknown
- 1994-05-19 IS IS4168A patent/IS1868B/is unknown
- 1994-05-20 MY MYPI94001305A patent/MY111445A/en unknown
- 1994-05-23 HR HR940315A patent/HRP940315B1/xx not_active IP Right Cessation
- 1994-05-23 AP APAP/P/1994/000643A patent/AP544A/en active
- 1994-05-23 CO CO94021615A patent/CO4230094A1/es unknown
- 1994-05-23 IE IE940420A patent/IE80632B1/en not_active IP Right Cessation
- 1994-05-23 PE PE1994242905A patent/PE13395A1/es not_active IP Right Cessation
- 1994-05-24 PL PL94311721A patent/PL175578B1/pl unknown
- 1994-05-24 US US08/537,950 patent/US5741806A/en not_active Expired - Lifetime
- 1994-05-24 AT AT94918355T patent/ATE183643T1/de active
- 1994-05-24 FR FR9406252A patent/FR2705569B1/fr not_active Expired - Lifetime
- 1994-05-24 KR KR1019950705280A patent/KR100297212B1/ko not_active IP Right Cessation
- 1994-05-24 RU RU95122578A patent/RU2132684C1/ru active
- 1994-05-24 IL IL10974994A patent/IL109749A/en not_active IP Right Cessation
- 1994-05-24 HU HU9503375A patent/HU227121B1/hu unknown
- 1994-05-24 IT ITRM940322A patent/IT1272990B/it active IP Right Grant
- 1994-05-24 SI SI9430263T patent/SI0700290T1/xx unknown
- 1994-05-24 ZA ZA943593A patent/ZA943593B/xx unknown
- 1994-05-24 WO PCT/EP1994/001652 patent/WO1994027599A1/en active IP Right Grant
- 1994-05-24 NZ NZ267415A patent/NZ267415A/en not_active IP Right Cessation
- 1994-05-24 CN CN94192243A patent/CN1106194C/zh not_active Expired - Lifetime
- 1994-05-24 DE DE69420266T patent/DE69420266T2/de not_active Expired - Lifetime
- 1994-05-24 BE BE9400528A patent/BE1007158A3/fr not_active IP Right Cessation
- 1994-05-24 DK DK94918355T patent/DK0700290T3/da active
- 1994-05-24 EP EP94918355A patent/EP0700290B1/en not_active Expired - Lifetime
- 1994-05-24 JP JP7500204A patent/JP2965703B2/ja not_active Expired - Lifetime
- 1994-05-24 AU AU69709/94A patent/AU680918B2/en not_active Expired
- 1994-05-24 ES ES94918355T patent/ES2136198T3/es not_active Expired - Lifetime
- 1994-05-24 CZ CZ19953085A patent/CZ291041B6/cs not_active IP Right Cessation
- 1994-05-24 CA CA002162919A patent/CA2162919C/en not_active Expired - Lifetime
- 1994-06-12 SA SA94150003A patent/SA94150003B1/ar unknown
-
1995
- 1995-11-24 NO NO954783A patent/NO306448B1/no not_active IP Right Cessation
-
1996
- 1996-09-19 BR BR1100046-5A patent/BR1100046A/pt active IP Right Grant
-
1997
- 1997-06-09 HR HR970315A patent/HRP970315A2/hr not_active Application Discontinuation
-
1999
- 1999-10-27 GR GR990402759T patent/GR3031669T3/el unknown
-
2000
- 2000-06-06 CY CY0000022A patent/CY2411B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9808429A (pt) | Composição farmacêutica e processo para a sua preparação. | |
| DE60039921D1 (de) | Hochaffine kleinmolekülige c5a-rezeptor-modulatoren | |
| AR027548A1 (es) | Derivados de amino pirazol utiles para el tratamiento de la obesidad y otros desordenes | |
| MXPA04002379A (es) | Compuestos novedosos. | |
| BG104877A (en) | N-substituted anminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders | |
| EE04911B1 (et) | Ühend ja farmatseutiline kompositsioon proteaasi inhibiitoritena, nende kasutamine ning meetod selle ühendi valmistamiseks | |
| IT1282353B1 (it) | Composizione farmaceutica, in particolare liquida, per sommanistrazione orale di ondansetron e metodi per la sua produzione | |
| PL372809A1 (en) | Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof | |
| ATE386725T1 (de) | Heterocyclylverbindungen | |
| DE69522945D1 (de) | Verbindungen, die als antiproliferative mittel und als garft inhibitoren verwendbar sind | |
| SE0102036D0 (sv) | Pharmaceutical formulation for the efficient administration of apomorphine, 6aR- (-) -N- Propyl- norapomorphine and their derivatives and pro-drugs thereof | |
| AR003966A1 (es) | Un derivado de difenilmetilenpiperidina, composición farmacéutica que lo contiene, metodo de preparación de dicho derivado y uso de este ultimo para preparar un medicamento | |
| DE69231663T2 (de) | Polysaccharid-protein-konjugate | |
| SE0102055D0 (sv) | New Compounds | |
| HUP0103203A2 (hu) | Azaadamantánszármazékok és ezeket tartalmazó gyógyszerkészítmények | |
| NO973652D0 (no) | 5-(4-subst.-piperidinyl-1)-3-aryl-pentansyre og derivater som tachykininreseptor-antagonist | |
| IT1272990B (it) | "composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione edapplicazione". | |
| ATE305921T1 (de) | Neue analoga von 16-hydroxyeicosatetraensäure | |
| IT1261471B (it) | Composizione farmaceutica per somministrazione rettale nel trattamentodi cefalea e relativo metodo di preparazione ed impiego. | |
| AU2001290480A1 (en) | Cyclized benzamide neurokinin antagonists for use in therapy | |
| PL350568A1 (en) | N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors | |
| AR035006A1 (es) | Derivado de naftiridin-dibenzo[a,d]ciclohepteno-10-acetico, composicion farmaceutica, y el uso de dicho derivado para la fabricacion de un medicamento. | |
| HUP9901208A2 (hu) | (R)-5-Bróm-n-(1-etil-4-metil-hexahidro-1H-1,4-diazepin-6-il)-2-metoxi-6-(metil-amino)-3-piridin-karboxamid, eljárás előállítására és ezt a vegyületet tartalmazó gyógyászati készítmény | |
| RU94046380A (ru) | Сульфатная соль замещенного триазола, способ ее получения, фармацевтические композиции на ее основе и способы их получения, способ профилактики и лечения | |
| DE60318716D1 (de) | Thieno-pyrrole verbindungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 0001 | Granted | ||
| TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19970530 |